Drugs News and Research

RSS

11 key measures for monitoring clinical activity during COVID-19

In a recent study posted to the medRxiv* preprint server, researchers in the United Kingdom described key measurements for monitoring clinical activity during the coronavirus disease 2019 (COVID-19) pandemic.

20 Oct 2022

Study develops a strategy to noninvasively track tumor-associated macrophages

A Ludwig Cancer Research study has developed a strategy to noninvasively track immune cells known as macrophages within brain and breast tumors in living mice.

19 Oct 2022

Antibodies can prevent surface proteins of bacteria from entering host cells

Using bacteria of the Bartonella henselae species, researchers from Goethe University, Frankfurt University Hospital, the Paul Ehrlich Federal Institute for Vaccines and Biomedicines in Langen, and the University of Oslo demonstrated for the first time that antibodies can prevent certain surface proteins of bacterial pathogens from entering host cells.

19 Oct 2022

Rare insect-eating mushrooms show potential to develop new anti-viral and cancer medications

Scientists studying the medicinal potential of a rare insect-eating mushroom have found a way to grow the elusive fungi in the lab, opening the way for the development of new anti-viral and cancer medications.

19 Oct 2022

AI app to read COVID-19 lateral flow tests helps to reduce false results

An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce false results in a new trial out today.

19 Oct 2022

Individualized treatment for back pain leads to increased effect compared to standard therapies

If a therapy for chronic back pain is tailored specifically to a patient's individual requirements, the chances of success are far greater than with standard forms of treatment.

18 Oct 2022

New machine learning model can screen novel drug compounds to accurately predict efficacy in humans

The journey between identifying a potential therapeutic compound and Food and Drug Administration approval of a new drug can take well over a decade and cost upwards of a billion dollars.

18 Oct 2022

Researchers assess wastewater sampling for SARS-CoV-2 surveillance

Researchers assessed the feasibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) surveillance using wastewater sampling.

18 Oct 2022

Scientists detect monkeypox virus in the testes of macaques during acute infection

For the first time, scientists have detected monkeypox virus in the testes of macaques during the acute phase of infection, according to research published online today in the journal Nature Microbiology.

17 Oct 2022

Illicit drugs associated with increased likelihood of developing atrial fibrillation

Methamphetamines, cocaine, opiates, and cannabis are associated with an increased likelihood of developing atrial fibrillation, according to an 11-year study in more than 23 million adults published today in European Heart Journal, a journal of the European Society of Cardiology.

17 Oct 2022

Newly identified brain molecule orchestrates the immune system's responses to Alzheimer's and MS

UVA Health researchers have discovered a molecule in the brain responsible for orchestrating the immune system's responses to Alzheimer's disease and multiple sclerosis (MS), potentially allowing doctors to supercharge the body's ability to fight those and other devastating neurological diseases.

17 Oct 2022

Genetic signature predicts tumor metastases and patient survival in clear cell kidney cancer

Among patients with kidney cancer, the activity of four specific genes in the cancer cells seems to be able to predict the risk of the tumor spreading and the patient's chances of survival.

17 Oct 2022

Novel drug target for triple-negative breast cancer discovered

Research led by Dr. Suresh Alahari, Professor of Biochemistry at LSU Health New Orleans' Schools of Medicine and Graduate Studies, reports a combination of a novel small inhibitory molecule and an FDA-approved chemotherapy drug suppresses the growth of triple-negative breast cancer cells synergistically.

17 Oct 2022

Study reviews hydroxychloroquine and remdesivir antiviral potency against SARS‐CoV‐2

In a new study, researchers outlined the synthesis and the possible mechanism of action (MOA) of two potential severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) repurposing drug candidates.

17 Oct 2022

Scientists identify group of genes shared between COVID-19 and diabetic kidney disease

Scientists identified five hub genes that might be associated with severe COVID-19 outcomes in patients with diabetic kidney disease.

17 Oct 2022

Researchers explore single-cell sequencing technologies to understand molecular mechanisms of autoimmune diseases

A new review discussed the applications of single-cell ribonucleic acid sequencing (scRNA-seq) in understanding autoimmune disorders.

17 Oct 2022

Exploring molecular docking and molecular dynamics simulations as advanced tools for novel antiviral drug discovery

Researchers presented an overview of factors influencing emerging infectious diseases. They also highlighted the importance of molecular dynamic (MD) simulations and molecular docking (MDO) analysis for combating these diseases.

17 Oct 2022

How the ‘love hormone’ oxytocin may have heart-healing properties

In this interview, News Medical speaks to Dr. Aitor Aguirre, Assistant Professor of Biomedical Engineering at Michigan State University, about how the ‘love hormone’ oxytocin may provide heart-healing properties.

17 Oct 2022

Selective immunoglobulin A deficiency a risk factor for severe COVID-19

In a recent study published in The Journal of Allergy and Clinical Immunology, researchers in New Zealand gathered evidence to show that selective immunoglobulin A deficiency (sIgAD) is an understated risk factor for severe coronavirus disease 2019 (COVID-19).

17 Oct 2022

Advances in nasal delivery of antibiotics

In a recent study published in the Journal of Drug Delivery Science and Technology, researchers reviewed the advances and challenges in the intranasal delivery of antibiotics.

17 Oct 2022

Drugs News and Research

11 key measures for monitoring clinical activity during COVID-19

Study develops a strategy to noninvasively track tumor-associated macrophages

Antibodies can prevent surface proteins of bacteria from entering host cells

Rare insect-eating mushrooms show potential to develop new anti-viral and cancer medications

AI app to read COVID-19 lateral flow tests helps to reduce false results

Individualized treatment for back pain leads to increased effect compared to standard therapies

New machine learning model can screen novel drug compounds to accurately predict efficacy in humans

Researchers assess wastewater sampling for SARS-CoV-2 surveillance

Scientists detect monkeypox virus in the testes of macaques during acute infection

Illicit drugs associated with increased likelihood of developing atrial fibrillation

Newly identified brain molecule orchestrates the immune system's responses to Alzheimer's and MS

Genetic signature predicts tumor metastases and patient survival in clear cell kidney cancer

Novel drug target for triple-negative breast cancer discovered

Study reviews hydroxychloroquine and remdesivir antiviral potency against SARS‐CoV‐2

Scientists identify group of genes shared between COVID-19 and diabetic kidney disease

Researchers explore single-cell sequencing technologies to understand molecular mechanisms of autoimmune diseases

Exploring molecular docking and molecular dynamics simulations as advanced tools for novel antiviral drug discovery

How the ‘love hormone’ oxytocin may have heart-healing properties

Selective immunoglobulin A deficiency a risk factor for severe COVID-19

Advances in nasal delivery of antibiotics

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News